BlackRock, Inc. 13D and 13G filings for ANI Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-10-17 6:05 pm Sale | 2025-09-30 | 13G | ANI PHARMACEUTICALS INC ANIP | BlackRock, Inc. BLK | 2,517,424 11.300% | -7,236 (-0.29%) | Filing |
| 2024-01-23 4:13 pm Purchase | 2023-12-31 | 13G | ANI PHARMACEUTICALS INC ANIP | BlackRock, Inc. BLK | 2,524,660 12.400% | 541,423 (+27.30%) | Filing |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | ANI PHARMACEUTICALS INC ANIP | BlackRock, Inc. BLK | 1,983,237 11.400% | 0 (Unchanged) | Filing |
| 2023-01-20 09:43 am Purchase | 2022-12-31 | 13G | ANI PHARMACEUTICALS INC ANIP | BlackRock, Inc. BLK | 1,983,237 11.400% | 296,624 (+17.59%) | Filing |
| 2022-02-07 4:41 pm Purchase | 2021-12-31 | 13G | ANI PHARMACEUTICALS INC ANIP | BlackRock, Inc. BLK | 1,686,613 11.800% | 97,385 (+6.13%) | Filing |